American Healthcare REIT, Inc. $AHR Stake Decreased by Greenland Capital Management LP

Greenland Capital Management LP trimmed its holdings in American Healthcare REIT, Inc. (NYSE:AHR) by 66.1% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 49,124 shares of the company’s stock after selling 95,876 shares during the quarter. Greenland Capital Management LP’s holdings in American Healthcare REIT were worth $1,805,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its holdings in shares of American Healthcare REIT by 22.1% during the second quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock valued at $63,000 after purchasing an additional 311 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in American Healthcare REIT by 1.4% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 29,300 shares of the company’s stock worth $1,086,000 after purchasing an additional 393 shares during the period. Lion Street Advisors LLC grew its position in American Healthcare REIT by 6.2% in the 2nd quarter. Lion Street Advisors LLC now owns 7,373 shares of the company’s stock valued at $271,000 after buying an additional 430 shares in the last quarter. Benjamin Edwards Inc. increased its stake in American Healthcare REIT by 3.2% during the 1st quarter. Benjamin Edwards Inc. now owns 14,368 shares of the company’s stock valued at $435,000 after buying an additional 444 shares during the period. Finally, J.Safra Asset Management Corp raised its position in shares of American Healthcare REIT by 8.3% during the 2nd quarter. J.Safra Asset Management Corp now owns 6,271 shares of the company’s stock worth $226,000 after buying an additional 480 shares in the last quarter. Institutional investors own 16.68% of the company’s stock.

Insider Buying and Selling

In other news, EVP Mark E. Foster sold 3,850 shares of the stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the transaction, the executive vice president owned 59,100 shares in the company, valued at $2,475,699. This represents a 6.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey T. Hanson sold 20,010 shares of American Healthcare REIT stock in a transaction on Monday, November 10th. The shares were sold at an average price of $49.68, for a total transaction of $994,096.80. Following the completion of the sale, the director directly owned 21,798 shares of the company’s stock, valued at approximately $1,082,924.64. The trade was a 47.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 25,360 shares of company stock worth $1,229,398 in the last 90 days. 1.00% of the stock is currently owned by corporate insiders.

American Healthcare REIT Price Performance

Shares of AHR opened at $49.16 on Wednesday. The business’s 50-day moving average is $43.81 and its 200-day moving average is $39.73. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.44 and a quick ratio of 0.44. The company has a market capitalization of $8.70 billion, a price-to-earnings ratio of 351.15, a P/E/G ratio of 2.34 and a beta of 0.98. American Healthcare REIT, Inc. has a fifty-two week low of $26.40 and a fifty-two week high of $50.51.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 2.0%. American Healthcare REIT’s payout ratio is presently 714.29%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Truist Financial upped their target price on American Healthcare REIT from $44.00 to $46.00 and gave the stock a “buy” rating in a research report on Tuesday, August 26th. Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a report on Friday, October 17th. Scotiabank boosted their target price on shares of American Healthcare REIT from $47.00 to $55.00 and gave the stock a “sector outperform” rating in a report on Thursday, November 13th. Royal Bank Of Canada raised their target price on shares of American Healthcare REIT from $45.00 to $54.00 and gave the stock an “outperform” rating in a report on Wednesday, November 12th. Finally, JMP Securities increased their price objective on American Healthcare REIT from $45.00 to $50.00 and gave the company a “market outperform” rating in a research report on Friday, October 17th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, American Healthcare REIT has an average rating of “Buy” and an average target price of $50.60.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.